|
293 Companies |
|
490 Products |
|
490 Products |
|
199 Mechanisms of Action |
|
25 Trials |
|
7787 News |
|
| «12...6667686970717273747576...156157» |
- Trial completion, Enrollment change, Trial primary completion date: Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR) (clinicaltrials.gov) - May 1, 2015
P=N/A, N=6, Completed, Sponsor: City of Hope Medical Center
Recruiting --> Completed | N=50 --> 6 | Trial primary completion date: Jun 2016 --> Apr 2015
- |||||||||| dimethyl fumarate / Generic mfg.
New P3 trial: INSPIRE: BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis (clinicaltrials.gov) - Apr 30, 2015
P3, N=1170, Not yet recruiting, Sponsor: Biogen Idec
- ||||| Bimzelx (bimekizumab) / UCB, Cimzia (certolizumab pegol) / Astellas, UCB
Clinical: Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis (clinicaltrials.gov) - Apr 30, 2015
P2, N=102, Recruiting, Sponsor: UCB Celltech
- Rituxan (rituximab) / Roche
Trial primary completion date: MAINRITSAN 2: Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis (clinicaltrials.gov) - Apr 30, 2015
P3, N=166, Active, not recruiting, Sponsor: Assistance Publique - H
Recruiting --> Completed | N=50 --> 6 | Trial primary completion date: Jun 2016 --> Apr 2015 Trial primary completion date: Aug 2017 --> Aug 2016
- Trial primary completion date: Is a Diet Necessary When Corticosteroid Treatment is Prescribed? (clinicaltrials.gov) - Apr 30, 2015
P=N/A, N=170, Active, not recruiting, Sponsor: Assistance Publique - H
Trial primary completion date: Aug 2017 --> Aug 2016 Trial primary completion date: Nov 2014 --> May 2015
- Enrollment closed, Trial primary completion date, IO biomarker: Auto-HTAP: Auto-immunity and Pulmonary Arterial Hypertension (clinicaltrials.gov) - Apr 30, 2015
P=N/A, N=629, Active, not recruiting, Sponsor: Assistance Publique - H
Trial primary completion date: Nov 2014 --> May 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Sep 2015
- ||||||| Kevzara (sarilumab) / Asahi Kasei, Regeneron, Sanofi
Trial completion: To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET) (clinicaltrials.gov) - Apr 30, 2015
P3, N=522, Completed, Sponsor: Sanofi
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2015 --> Sep 2015 Active, not recruiting --> Completed
- |||| dimethyl fumarate / Generic mfg.
Enrollment open, Adherence: Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients. (clinicaltrials.gov) - Apr 29, 2015
P4, N=450, Recruiting, Sponsor: Biogen Idec
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment open: Wireless Motion Sensors for Rheumatoid Arthritis Patients - Pilot Study (clinicaltrials.gov) - Apr 29, 2015
P=N/A, N=7, Recruiting, Sponsor: Cedars-Sinai Medical Center
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- || glatiramer acetate / Generic mfg., dimethyl fumarate / Generic mfg.
Enrollment closed, Trial primary completion date, Patient reported outcomes: Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS (clinicaltrials.gov) - Apr 29, 2015
P=N/A, N=333, Active, not recruiting, Sponsor: Biogen Idec
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Mar 2016
- ||| Tysabri (natalizumab) / Biogen, Royalty
Clinical data, Trial completion, Enrollment change, Real-world evidence, Real-world: Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab) (clinicaltrials.gov) - Apr 29, 2015
P=N/A, N=530, Completed, Sponsor: Biogen Idec
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Mar 2016 Recruiting --> Completed | N=700 --> 530
- |||||| Enbrel (etanercept) / Pfizer, Amgen
Enrollment open: Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects (clinicaltrials.gov) - Apr 29, 2015
P3, N=180, Recruiting, Sponsor: Pfizer
Recruiting --> Completed | N=700 --> 530 Not yet recruiting --> Recruiting
- Trial primary completion date: Effects of Sustained Reading on the Ocular Surface (clinicaltrials.gov) - Apr 28, 2015
P=N/A, N=40, Recruiting, Sponsor: University of Rochester
Not yet recruiting --> Recruiting Trial primary completion date: Nov 2015 --> Apr 2016
- |||||||||| dimethyl fumarate / Generic mfg.
New P3 trial, Adverse events: Tecfidera Slow-titration Study (clinicaltrials.gov) - Apr 28, 2015
P3, N=300, Not yet recruiting, Sponsor: Biogen Idec
- |||||||||| dimethyl fumarate / Generic mfg.
New P3 trial: Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) (clinicaltrials.gov) - Apr 28, 2015
P3, N=172, Not yet recruiting, Sponsor: Biogen Idec
- New P1/2 trial, Preclinical: SCLEROLYM: A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple Sclerosis (clinicaltrials.gov) - Apr 28, 2015
P1/2, N=18, Recruiting, Sponsor: ImCyse
- Enrollment open: REPLACE-BG: A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 Diabetes (clinicaltrials.gov) - Apr 28, 2015
P=N/A, N=250, Recruiting, Sponsor: T1D Exchange Clinic Network Coordinating Center
Trial primary completion date: Nov 2015 --> Apr 2016 Not yet recruiting --> Recruiting
- || Enrollment closed, Trial primary completion date: Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP) (clinicaltrials.gov) - Apr 28, 2015
P=N/A, N=160, Active, not recruiting, Sponsor: Park Nicollet Institute
Not yet recruiting --> Recruiting Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jan 2015 --> Jul 2015
- | Victoza (liraglutide) / Novo Nordisk
Trial completion: ADJUNCT TWO: The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes (clinicaltrials.gov) - Apr 28, 2015
P3, N=835, Completed, Sponsor: Novo Nordisk A/S
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jan 2015 --> Jul 2015 Active, not recruiting --> Completed
- || Tysabri (natalizumab) / Biogen, Royalty
Trial primary completion date: TYGRIS: TYSABRI Global Observational Program in Safety (clinicaltrials.gov) - Apr 27, 2015
P=N/A, N=2207, Active, not recruiting, Sponsor: Biogen Idec
Active, not recruiting --> Completed Trial primary completion date: Sep 2014 --> May 2015
- ||||||| tacrolimus oral / Generic mfg.
Trial completion: A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis (clinicaltrials.gov) - Apr 27, 2015
P3, N=83, Completed, Sponsor: Astellas Pharma Inc
Trial primary completion date: Sep 2014 --> May 2015 Active, not recruiting --> Completed
- Trial completion: Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration (clinicaltrials.gov) - Apr 27, 2015
P=N/A, N=10, Completed, Sponsor: Medical University of Graz
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Trial primary completion date: Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. (clinicaltrials.gov) - Apr 25, 2015
P3, N=156, Recruiting, Sponsor: Novartis Pharmaceuticals
Active, not recruiting --> Completed Trial primary completion date: Feb 2016 --> Feb 2017
- || Biomarker, Enrollment closed: A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers (clinicaltrials.gov) - Apr 25, 2015
P0, N=78, Active, not recruiting, Sponsor: Janssen Research & Development, LLC
Trial primary completion date: Feb 2016 --> Feb 2017 Recruiting --> Active, not recruiting
- Disalcid (salsalate) / Bausch Health
Trial completion, Enrollment change: Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy (clinicaltrials.gov) - Apr 25, 2015
P2, N=8, Completed, Sponsor: University of Michigan
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | N=10 --> 8
- | Rituxan (rituximab) / Roche
Trial completion, Enrollment change, Trial primary completion date: Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis (clinicaltrials.gov) - Apr 25, 2015
P3, N=156, Completed, Sponsor: Frank Behrens
Active, not recruiting --> Completed | N=10 --> 8 Recruiting --> Completed | N=270 --> 156 | Trial primary completion date: Dec 2013 --> Feb 2015
- mycophenolate mofetil / Generic mfg., azathioprine / Generic mfg.
Trial completion, Enrollment change: Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis (clinicaltrials.gov) - Apr 25, 2015
P=N/A, N=206, Completed, Sponsor: Zhi-Hong Liu, M.D.
Recruiting --> Completed | N=270 --> 156 | Trial primary completion date: Dec 2013 --> Feb 2015 Recruiting --> Completed | N=150 --> 206
- Trial primary completion date: Walking With FES or AFO in People With MS With Foot Drop (clinicaltrials.gov) - Apr 23, 2015
P=N/A, N=24, Recruiting, Sponsor: Queen Margaret University
Recruiting --> Completed | N=150 --> 206 Trial primary completion date: Mar 2015 --> Mar 2016
- Trial primary completion date: Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot Drop (clinicaltrials.gov) - Apr 23, 2015
P=N/A, N=10, Recruiting, Sponsor: Queen Margaret University
Trial primary completion date: Mar 2015 --> Mar 2016 Trial primary completion date: Mar 2015 --> Oct 2015
- New trial: SandRA: Cell Phone Based Automated Monitoring of Patients With Early Rheumatoid Arthritis (clinicaltrials.gov) - Apr 23, 2015
P=N/A, N=200, Recruiting, Sponsor: Medcare Oy
- || Enrollment status: The CARRA Registry (clinicaltrials.gov) - Apr 23, 2015
P=N/A, N=10000, Enrolling by invitation, Sponsor: Duke University
Trial primary completion date: Mar 2015 --> Oct 2015 Recruiting --> Enrolling by invitation
- || Betaseron (IFN-β-1b) / Bayer
Enrollment closed: Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis (clinicaltrials.gov) - Apr 22, 2015
P=N/A, N=1125, Active, not recruiting, Sponsor: Bayer
Recruiting --> Enrolling by invitation Recruiting --> Active, not recruiting
- ||||||| Plivensia (sirukumab) / J&J
Trial completion, Monotherapy: A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine (clinicaltrials.gov) - Apr 22, 2015
P3, N=122, Completed, Sponsor: Janssen Pharmaceutical K.K.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial primary completion date: The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Apr 22, 2015
P=N/A, N=110, Recruiting, Sponsor: Ottawa Hospital Research Institute
Active, not recruiting --> Completed Trial primary completion date: Mar 2015 --> Jan 2016
- Oshadi Icp (insulin oral) / Oshadi Drug Administration
Trial primary completion date: Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study (clinicaltrials.gov) - Apr 22, 2015
P2, N=12, Recruiting, Sponsor: Oshadi Drug Administration
Trial primary completion date: Mar 2015 --> Jan 2016 Trial primary completion date: Nov 2014 --> Apr 2016
- bortezomib / Generic mfg.
Trial primary completion date: CAD0111: Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease (clinicaltrials.gov) - Apr 22, 2015
P2, N=25, Recruiting, Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Trial primary completion date: Nov 2014 --> Apr 2016 Trial primary completion date: Mar 2015 --> Mar 2016
- dexamethasone / Generic mfg., prednisone / Generic mfg.
Trial primary completion date: GIMEMA Protocol ITP0207: Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura (clinicaltrials.gov) - Apr 22, 2015
P3, N=150, Recruiting, Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Trial primary completion date: Mar 2015 --> Mar 2016 Trial primary completion date: Mar 2015 --> Mar 2016
- New trial: EASEDIAP: Education Effectiveness for Type 1 Diabetes Mellitus on Insulin Pump Therapy (clinicaltrials.gov) - Apr 22, 2015
P=N/A, N=77, Completed, Sponsor: Endocrinology Research Centre, Moscow
- ||| New trial: Three-dimensional Measurements of Diabetic Foot Ulcers (clinicaltrials.gov) - Apr 22, 2015
P=N/A, N=150, Not yet recruiting, Sponsor: Odense University Hospital
- | Trial completion, Trial initiation date, HEOR: Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyro (clinicaltrials.gov) - Apr 22, 2015
P3, N=200, Completed, Sponsor: Assistance Publique Hopitaux De Marseille
Trial primary completion date: Mar 2015 --> Mar 2016 Recruiting --> Completed | Initiation date: Dec 2010 --> May 2011
- Trial primary completion date, Pneumococcal vaccines: VACCILUP: Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus (clinicaltrials.gov) - Apr 21, 2015
P2/3, N=106, Active, not recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Completed | Initiation date: Dec 2010 --> May 2011 Trial primary completion date: Jun 2014 --> Dec 2014
- || Humira (adalimumab) / Eisai, AbbVie
Trial initiation date: ORIENT: Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=100, Not yet recruiting, Sponsor: AbbVie
Trial primary completion date: Jun 2014 --> Dec 2014 Initiation date: Mar 2015 --> Jun 2015
- || New P3 trial: A Task-oriented Circuit Training in Multiple Sclerosis (clinicaltrials.gov) - Apr 21, 2015
P3, N=60, Recruiting, Sponsor: University Hospital of Ferrara
- Enrollment closed, Enrollment change: BHYRRA: Effect Assessment of Periodontal Prophylaxis on Rheumatoid Arthritis Activity. (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=92, Active, not recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Initiation date: Mar 2015 --> Jun 2015 Recruiting --> Active, not recruiting | N=200 --> 92
- Enrollment closed, Trial primary completion date: Interest of a Standardized Monitoring of Rheumatoid Arthritis: The COMEDRA Trial (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=970, Active, not recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Active, not recruiting | N=200 --> 92 Suspended --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Oct 2016
- Trial completion: DAP12WEGENER: Study of One Protein Implicated in Wegener Disease (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=138, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Suspended --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Oct 2016 Active, not recruiting --> Completed
- Novolin R (recombinant human insulin) / Novo Nordisk
Trial primary completion date: Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia (clinicaltrials.gov) - Apr 21, 2015
P2, N=20, Enrolling by invitation, Sponsor: Medical University of Graz
Active, not recruiting --> Completed Trial primary completion date: Mar 2015 --> Sep 2015
- || Trial primary completion date: EPICOM: Study of Offspring of Women With Type 1 Diabetes (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=584, Active, not recruiting, Sponsor: Odense University Hospital
Trial primary completion date: Mar 2015 --> Sep 2015 Trial primary completion date: Aug 2014 --> Aug 2015
- Trial primary completion date: Allerdiab: Diagnosis and Physiopathology of Insulin Allergy (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=70, Recruiting, Sponsor: Assistance Publique - H
Trial primary completion date: Aug 2014 --> Aug 2015 Trial primary completion date: Aug 2015 --> Dec 2016
- ||| Biomarker, New trial: A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=80, Recruiting, Sponsor: Biogen Idec